title: Should evidence-based proof of efficacy as defined for a specific therapeutic agent be extrapolated to encompass a therapeutic class of agents?
authors.affiliation: Cardiovascular Division, Brigham and Women's Hospital, 75 Francis St, Boston, Mass 02115, USA. eantman@rics.bwh.harvard.edu
authors.forename: Elliott M
authors.initials: EM
authors.lastname: Antman
authors.forename: James J
authors.initials: JJ
authors.lastname: Ferguson
mesh_terms: D004358:Drug Therapy / Q000592:standards*; D019317:Evidence-Based Medicine / Q000592:standards*; D006801:Humans; D004364:Pharmaceutical Preparations / Q000737:chemistry / Q000145:classification / Q000592:standards*; D018570:Risk Assessment; D013810:Therapeutic Equivalency; D016896:Treatment Outcome
chemical_list: D004364:Pharmaceutical Preparations